PHB2_HUMAN - dbPTM
PHB2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PHB2_HUMAN
UniProt AC Q99623
Protein Name Prohibitin-2
Gene Name PHB2 {ECO:0000312|EMBL:AAH14766.1, ECO:0000312|HGNC:HGNC:30306}
Organism Homo sapiens (Human).
Sequence Length 299
Subcellular Localization Mitochondrion inner membrane . Cytoplasm . Nucleus .
Protein Description Acts as a mediator of transcriptional repression by nuclear hormone receptors via recruitment of histone deacetylases (By similarity). Functions as an estrogen receptor (ER)-selective coregulator that potentiates the inhibitory activities of antiestrogens and represses the activity of estrogens. Competes with NCOA1 for modulation of ER transcriptional activity. Probably involved in regulating mitochondrial respiration activity and in aging..
Protein Sequence MAQNLKDLAGRLPAGPRGMGTALKLLLGAGAVAYGVRESVFTVEGGHRAIFFNRIGGVQQDTILAEGLHFRIPWFQYPIIYDIRARPRKISSPTGSKDLQMVNISLRVLSRPNAQELPSMYQRLGLDYEERVLPSIVNEVLKSVVAKFNASQLITQRAQVSLLIRRELTERAKDFSLILDDVAITELSFSREYTAAVEAKQVAQQEAQRAQFLVEKAKQEQRQKIVQAEGEAEAAKMLGEALSKNPGYIKLRKIRAAQNISKTIATSQNRIYLTADNLVLNLQDESFTRGSDSLIKGKK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAQNLKDLA
------CCCCHHHHC
13.6322814378
6Methylation--MAQNLKDLAGRLP
--CCCCHHHHCCCCC
59.24-
6Acetylation--MAQNLKDLAGRLP
--CCCCHHHHCCCCC
59.2427452117
62-Hydroxyisobutyrylation--MAQNLKDLAGRLP
--CCCCHHHHCCCCC
59.24-
6Succinylation--MAQNLKDLAGRLP
--CCCCHHHHCCCCC
59.2423954790
6Ubiquitination--MAQNLKDLAGRLP
--CCCCHHHHCCCCC
59.2421890473
6Ubiquitination--MAQNLKDLAGRLP
--CCCCHHHHCCCCC
59.2421890473
21PhosphorylationAGPRGMGTALKLLLG
CCCCCHHHHHHHHHH
21.6621406692
24AcetylationRGMGTALKLLLGAGA
CCHHHHHHHHHHCCH
34.3326051181
34PhosphorylationLGAGAVAYGVRESVF
HHCCHHCCEEECCEE
15.0028152594
77PhosphorylationFRIPWFQYPIIYDIR
EECCCCCCCEEEEEC
6.2117360941
81PhosphorylationWFQYPIIYDIRARPR
CCCCCEEEEECCCCC
13.1622817900
89SuccinylationDIRARPRKISSPTGS
EECCCCCCCCCCCCC
50.0127452117
89UbiquitinationDIRARPRKISSPTGS
EECCCCCCCCCCCCC
50.0122817900
91PhosphorylationRARPRKISSPTGSKD
CCCCCCCCCCCCCCC
33.0430266825
92PhosphorylationARPRKISSPTGSKDL
CCCCCCCCCCCCCCC
29.9225849741
94PhosphorylationPRKISSPTGSKDLQM
CCCCCCCCCCCCCEE
56.9130266825
96O-linked_GlycosylationKISSPTGSKDLQMVN
CCCCCCCCCCCEEEE
26.0230379171
96PhosphorylationKISSPTGSKDLQMVN
CCCCCCCCCCCEEEE
26.0223403867
97AcetylationISSPTGSKDLQMVNI
CCCCCCCCCCEEEEE
64.9026051181
972-HydroxyisobutyrylationISSPTGSKDLQMVNI
CCCCCCCCCCEEEEE
64.90-
97UbiquitinationISSPTGSKDLQMVNI
CCCCCCCCCCEEEEE
64.9022817900
97UbiquitinationISSPTGSKDLQMVNI
CCCCCCCCCCEEEEE
64.9021890473
101SulfoxidationTGSKDLQMVNISLRV
CCCCCCEEEEEEEEE
3.0321406390
105PhosphorylationDLQMVNISLRVLSRP
CCEEEEEEEEEHHCC
12.6221712546
119PhosphorylationPNAQELPSMYQRLGL
CCHHHCCHHHHHHCC
42.6228152594
120SulfoxidationNAQELPSMYQRLGLD
CHHHCCHHHHHHCCC
2.8928183972
121PhosphorylationAQELPSMYQRLGLDY
HHHCCHHHHHHCCCH
8.5328152594
123MethylationELPSMYQRLGLDYEE
HCCHHHHHHCCCHHH
17.15-
128PhosphorylationYQRLGLDYEERVLPS
HHHHCCCHHHCHHHH
25.4022817900
135PhosphorylationYEERVLPSIVNEVLK
HHHCHHHHHHHHHHH
34.7020068231
142UbiquitinationSIVNEVLKSVVAKFN
HHHHHHHHHHHHHCC
46.5122817900
147UbiquitinationVLKSVVAKFNASQLI
HHHHHHHHCCHHHHH
27.7827667366
147UbiquitinationVLKSVVAKFNASQLI
HHHHHHHHCCHHHHH
27.7821890473
147AcetylationVLKSVVAKFNASQLI
HHHHHHHHCCHHHHH
27.7825825284
1472-HydroxyisobutyrylationVLKSVVAKFNASQLI
HHHHHHHHCCHHHHH
27.78-
151PhosphorylationVVAKFNASQLITQRA
HHHHCCHHHHHHHHH
26.9921712546
155PhosphorylationFNASQLITQRAQVSL
CCHHHHHHHHHHHHH
22.1630108239
161PhosphorylationITQRAQVSLLIRREL
HHHHHHHHHHHHHHH
12.8423312004
169PhosphorylationLLIRRELTERAKDFS
HHHHHHHHHHHHHCE
20.7626437602
176PhosphorylationTERAKDFSLILDDVA
HHHHHHCEEEECCHH
25.32-
193PhosphorylationELSFSREYTAAVEAK
EECCCHHHHHHHHHH
10.6828152594
194PhosphorylationLSFSREYTAAVEAKQ
ECCCHHHHHHHHHHH
11.9128152594
200SuccinylationYTAAVEAKQVAQQEA
HHHHHHHHHHHHHHH
31.6227452117
2002-HydroxyisobutyrylationYTAAVEAKQVAQQEA
HHHHHHHHHHHHHHH
31.62-
200UbiquitinationYTAAVEAKQVAQQEA
HHHHHHHHHHHHHHH
31.6227667366
200AcetylationYTAAVEAKQVAQQEA
HHHHHHHHHHHHHHH
31.6223236377
206UbiquitinationAKQVAQQEAQRAQFL
HHHHHHHHHHHHHHH
34.3923503661
212UbiquitinationQEAQRAQFLVEKAKQ
HHHHHHHHHHHHHHH
8.8922817900
215UbiquitinationQRAQFLVEKAKQEQR
HHHHHHHHHHHHHHH
49.8222817900
2162-HydroxyisobutyrylationRAQFLVEKAKQEQRQ
HHHHHHHHHHHHHHH
54.10-
216AcetylationRAQFLVEKAKQEQRQ
HHHHHHHHHHHHHHH
54.1023749302
216MalonylationRAQFLVEKAKQEQRQ
HHHHHHHHHHHHHHH
54.1026320211
216UbiquitinationRAQFLVEKAKQEQRQ
HHHHHHHHHHHHHHH
54.1027667366
218UbiquitinationQFLVEKAKQEQRQKI
HHHHHHHHHHHHHHH
66.4922817900
224UbiquitinationAKQEQRQKIVQAEGE
HHHHHHHHHHHHHHH
47.2123000965
224AcetylationAKQEQRQKIVQAEGE
HHHHHHHHHHHHHHH
47.2126051181
2242-HydroxyisobutyrylationAKQEQRQKIVQAEGE
HHHHHHHHHHHHHHH
47.21-
2362-HydroxyisobutyrylationEGEAEAAKMLGEALS
HHHHHHHHHHHHHHH
41.53-
236AcetylationEGEAEAAKMLGEALS
HHHHHHHHHHHHHHH
41.5325953088
236UbiquitinationEGEAEAAKMLGEALS
HHHHHHHHHHHHHHH
41.5321906983
236NeddylationEGEAEAAKMLGEALS
HHHHHHHHHHHHHHH
41.5332015554
237SulfoxidationGEAEAAKMLGEALSK
HHHHHHHHHHHHHHH
5.0821406390
243PhosphorylationKMLGEALSKNPGYIK
HHHHHHHHHCCCCCH
37.1222817900
244UbiquitinationMLGEALSKNPGYIKL
HHHHHHHHCCCCCHH
68.9323000965
244AcetylationMLGEALSKNPGYIKL
HHHHHHHHCCCCCHH
68.9325953088
244NeddylationMLGEALSKNPGYIKL
HHHHHHHHCCCCCHH
68.9332015554
248PhosphorylationALSKNPGYIKLRKIR
HHHHCCCCCHHHHHH
8.9921082442
250UbiquitinationSKNPGYIKLRKIRAA
HHCCCCCHHHHHHHH
33.4823000965
250AcetylationSKNPGYIKLRKIRAA
HHCCCCCHHHHHHHH
33.4819608861
2502-HydroxyisobutyrylationSKNPGYIKLRKIRAA
HHCCCCCHHHHHHHH
33.48-
253UbiquitinationPGYIKLRKIRAAQNI
CCCCHHHHHHHHHHH
47.1622817900
258UbiquitinationLRKIRAAQNISKTIA
HHHHHHHHHHCHHHH
46.9733845483
261UbiquitinationIRAAQNISKTIATSQ
HHHHHHHCHHHHCCC
31.1524816145
262UbiquitinationRAAQNISKTIATSQN
HHHHHHCHHHHCCCC
39.9023000965
262MalonylationRAAQNISKTIATSQN
HHHHHHCHHHHCCCC
39.9026320211
262AcetylationRAAQNISKTIATSQN
HHHHHHCHHHHCCCC
39.9025953088
2622-HydroxyisobutyrylationRAAQNISKTIATSQN
HHHHHHCHHHHCCCC
39.90-
263PhosphorylationAAQNISKTIATSQNR
HHHHHCHHHHCCCCE
14.7326437602
266PhosphorylationNISKTIATSQNRIYL
HHCHHHHCCCCEEEE
27.3126437602
267PhosphorylationISKTIATSQNRIYLT
HCHHHHCCCCEEEEE
19.2128985074
286PhosphorylationVLNLQDESFTRGSDS
EEECCCCCCCCCCCC
39.9625159151
288PhosphorylationNLQDESFTRGSDSLI
ECCCCCCCCCCCCCC
43.3229496963
289MethylationLQDESFTRGSDSLIK
CCCCCCCCCCCCCCC
40.38-
291PhosphorylationDESFTRGSDSLIKGK
CCCCCCCCCCCCCCC
22.2730266825
293PhosphorylationSFTRGSDSLIKGKK-
CCCCCCCCCCCCCC-
33.4230266825
296UbiquitinationRGSDSLIKGKK----
CCCCCCCCCCC----
70.7121906983
296AcetylationRGSDSLIKGKK----
CCCCCCCCCCC----
70.7125953088
299UbiquitinationDSLIKGKK-------
CCCCCCCC-------
74.3924816145

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
39SPhosphorylationKinasePKCAP17252
PSP
91SPhosphorylationKinaseAKT1P31749
PSP
91SPhosphorylationKinaseAKT2P31751
PSP
91SPhosphorylationKinaseCAMK4Q16566
PSP
176SPhosphorylationKinaseAKT1P31749
PSP
176SPhosphorylationKinaseAKT2P31751
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PHB2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PHB2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CTNB1_HUMANCTNNB1physical
17353931
PLAK_HUMANJUPphysical
17353931
NU205_HUMANNUP205physical
17353931
UBP15_HUMANUSP15physical
17353931
MMS19_HUMANMMS19physical
17353931
PDXD1_HUMANPDXDC1physical
17353931
DDX20_HUMANDDX20physical
17353931
NUP93_HUMANNUP93physical
17353931
RUNX3_HUMANRUNX3physical
17353931
TIM50_HUMANTIMM50physical
17353931
EPIPL_HUMANEPPK1physical
17353931
COPG1_HUMANCOPG1physical
17353931
LG3BP_HUMANLGALS3BPphysical
17353931
PTMA_HUMANPTMAphysical
12943695
HDAC1_HUMANHDAC1physical
15140878
HDAC5_HUMANHDAC5physical
15140878
ESR1_HUMANESR1physical
15140878
COT1_HUMANNR2F1physical
15140878
COT2_HUMANNR2F2physical
15140878
ESR1_HUMANESR1physical
17932104
PHB_HUMANPHBphysical
17932104
ESR1_HUMANESR1physical
10938099
BIG3_HUMANKIAA1244physical
19496786
QCR1_HUMANUQCRC1physical
22939629
MYOD1_HUMANMYOD1physical
15173318
MEF2A_HUMANMEF2Aphysical
15173318
HDAC1_HUMANHDAC1physical
15173318
FHL2_HUMANFHL2physical
18255255
TEAD3_HUMANTEAD3physical
21988832
BIG3_HUMANKIAA1244physical
24051437
ESR1_HUMANESR1physical
24051437
HDAC1_HUMANHDAC1physical
24051437
NCOR1_HUMANNCOR1physical
24051437
XIAP_HUMANXIAPphysical
26186194
NMRL1_HUMANNMRAL1physical
26186194
VATC1_HUMANATP6V1C1physical
26344197
CCD47_HUMANCCDC47physical
26344197
COX41_HUMANCOX4I1physical
26344197
GOSR1_HUMANGOSR1physical
26344197
LEG1_HUMANLGALS1physical
26344197
RM17_HUMANMRPL17physical
26344197
NDUB8_HUMANNDUFB8physical
26344197
PHB_HUMANPHBphysical
26344197
PTBP1_HUMANPTBP1physical
26344197
SSRA_HUMANSSR1physical
26344197
NMRL1_HUMANNMRAL1physical
28514442
XIAP_HUMANXIAPphysical
28514442
STOM_HUMANSTOMphysical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PHB2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-250, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-248, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-128, AND MASSSPECTROMETRY.

TOP